SEC Filings | Landos Biopharma

Filing date	Form	Description	View
01/28/21	CORRESP	CORRESP	0001193125-21-020158.pdf 112.2 KB 0001193125-21-020158.rtf View HTML
02/01/21	CORRESP	CORRESP	0001193125-21-024836.pdf 152.9 KB 0001193125-21-024836.rtf View HTML
02/01/21	CORRESP	CORRESP	0001193125-21-024641.pdf 77.1 KB 0001193125-21-024641.rtf 0001193125-21-024641.xls View HTML
08/11/22	CORRESP	CORRESP	0001193125-22-218093.pdf 0001193125-22-218093.rtf 0001193125-22-218093.xls View HTML
05/16/22	CORRESP	CORRESP	0001193125-22-151650.pdf 0001193125-22-151650.rtf 0001193125-22-151650.xls View HTML
05/18/22	CORRESP	CORRESP	0001193125-22-153928.pdf 0001193125-22-153928.rtf 0001193125-22-153928.xls View HTML
08/23/19	D	Notice of Exempt Offering of Securities	0001785345-19-000001.pdf 95.6 KB 0001785345-19-000001.rtf View HTML
04/28/22	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-22-127596.pdf 0001193125-22-127596.rtf 0001193125-22-127596.xls View HTML
04/19/23	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0000950170-23-013359.pdf 0000950170-23-013359.rtf 0000950170-23-013359.xls View HTML
04/28/22	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-22-127644.pdf 0001193125-22-127644.rtf View HTML

Data provided by Kaleidoscope.